COVID-19 vaccine
The EU has reached an agreement with Sanofi for 300 million doses of their COVID-19 vaccine candidate which will allow the trading bloc’s members to purchase the vaccines if and when it gets an approval.
This is part of a wider strategy the EU is pursuing. They have set aside a fund of $2.4 billion to strike separate deals with multiple pharmaceutical companies developing vaccines to ensure the EU’s 450 million citizens have access to a potential treatment.
Image caption: Photo by MPD01605
